Biotech Investment Summit Biotech Investment Summit
Download Brochure Request

Register your interest


Register your interest


Biotech Investment Summit

31 October – 2 November 2018, One Farrer Hotel & Spa, Singapore

Book Now Download Brochure



Co Located with BioPharma Development and Production Week, the Biotech Investment Summit will bring together top deal makers from local and international financial markets, and the biotech industry. Central to the conference objectives will be connecting investors with biotech, against the backdrop of company showcases, emerging market opportunities and a specific focus on China. In addition, practical tools for investment appraisal, due diligence and deal structuring tactics will be discussed.


Showcase your company!

Are you an investor, or biotech company seeking finance? Contact us with a brief pitch to make your case for being a speaker.

Discussion topics being explored:

  • Global and Asian investment and financing trends
  • Mega Trends and Innovation – what’s happening in Biotech and how will it impact investment flow
  • Investor psychology – perspectives from VCs, Funds, PE and Institutional investors
  • Segmenting the investment opportunities – where is the money?
  • Divestiture and M&A trends, and what to expect
  • IPO outlook
  • Company showcase from emerging markets
  • Evaluating and investing in China based companies
  • Small biotech showcase and shareholding opportunities
  • Financing clinical trials
  • Raising finance for greenfield manufacturing site projects
  • Pitching your company to investors
  • Due diligence of biotech companies
  • Regulatory considerations and Antitrust law for biotech
  • Deal Structuring

Choose your language

Part of

Biopharma Development & Production Asia >>

Co-Located Events

Bioprocess and Technology >>
Biopharma SCMInnovate >>
Biotech Investment Summit >>


8:00 am

Registration Opens

8:50 am

Chairperson’s Opening Remarks

9:00 am

  • Translational research to understand local unmet medical need
  • Addressing ethnic difference through innovative science and development strategies
  • Contributing to collaborative R&D ecosystem to ensure quality

9:30 am

  • AI applications in biopharma market value chain – R&D, clinical trials, business process management and supply chain
  • Using AI tools in pharma – How Asia is progressing?

10:00 am

10:40 am

Morning Break and Networking. End of opening plenary and Biotech Investment Summit Commence

11:20 am

Chairperson’s Opening Remarks


11:30 am

  • How will humanity change in the future, healthspan and lifespan, comparing the trends in the past and the future
  • How should humans be treated for clinical medicine and cures, now and the ideal scenario.
  • How is biotech making this changes, and what next after biotech
  • What are the global initiatives and trends that will most impact humanity
  • Invested project case studies: Samumed, Sisaf and Atomwise

12:00 pm

  • Funding and Investments in value – Total funding capital amount of US$200M since 2001
  • Case study on drug approval – First Class 1.1 China new drug approved by CFDA
  • Impact of alliances: Forming TaiGen and HEC in China, conducted first DDA trial and bring it to market

12:30 pm

  • Case study on startup funding for drug discovery
  • Leveraging experts in biology and drug discovery to create a new way to buildnovel medicines
  • Understanding how technology can be better used for discovery and funding

1:00 pm

Networking Lunch

2:00 pm

  • Investment opportunities and partnerships in the Chronic disease segment
  • Unique and advanced technologies showcase
  • Expanding plan in Asia

Speaking opportunity, please contact

2:30 pm

  • Bridging the insurmountable gaps from academia to new drug development
  • Establishing a scientific platform by confirmation of multiple converging new drug targets
  • Incremental success can lead to paradigm shift in CNS drug discovery

3:00 pm

  • Maximize the value of big data and genomic beyond diagnostic
  • Leap into first in class drugs with less money and shorter time
  • Integrate the resources from both US and Asia
  • Attack the toughest diseases with precision medicine

3:30 pm

Afternoon Break and Networking


4:50 pm

  • Obtaining key criteria –project valuation and how lenders use to assess your application
  • Financing and investment models in biotechnology ventures
  • Managing risks – Regulation, listing strategies and market scenarios
  • Where do we see the investment hotspots in Asia?

5:30 pm

End of Conference Day 1

8:50 am

Chairperson’s Opening Remarks


9:00 am

  • Major Progress update in biotechnology development: Gene & Cell therapy
  • Uncovering the barriers to development ATMP
  • Supporting and financing and risk management

9:30 am

  • Technology and market roadmap
  • Deal Structuring and Investment documentation
  • Capital raising through syndication of world-class investors

10:00 am

  • Indian Novel drug sector overview and market outlook
  • Unique technology trends
  • Smarter clinical development
  • Robust pipeline showcase

10:30 am

Morning Break and Networking


11:00 am

  • How do venture capitals to evaluate investments?
  • How to have successful IPOs strategy?
  • Listing and IPO criteria and regulatory requirements
  • How to evaluate the risk factors when investing in early-stage start ups

11:30 am

  • The Hong Kong IPO market – new regulations and opportunities
  • Draws GIC to first pre-profit biotech IPO
  • Experience sharing on successful listing
  • Market potential in China and Hong Kong

*Awaiting final confirmation


12:00 pm

  • Increasing prevalence of western cancers in Asia
  • Understanding the economics of treatment
  • Global shift in treatment paradigms
  • Need to address underserved Asian specific cancers
  • Need for Asia centric development

12:30 pm

  • Investment in clinical-stage biotechnology with T-Cell development focus
  • Latest technology in TCR-T cell therapy
  • Leading projects showcase and extending

1:00 pm

Networking Lunch


2:00 pm

  • Build your case with unique and strong data support
  • Identify the best partner
  • Pursue the ideal deal structure- Legend-Janssen case study
  • Closing the deal with every available support

2:30 pm

  • Partnership opportunities
  • Next innovative drugs in China- Asia’s largest new drug developer
  • Innovation and implementing landscapes

3:00 pm

  • Strategic research collaboration and license options
  • Better understanding and awareness about the benefits of AI-led technologies
  • Intelligent technologies showcase- AI, IoT, RPA, machine learning and data analysis

3:30 pm

Afternoon Break and Networking


4:00 pm

  • Towards Industry 4.0 – where are we at now?
  • Reviewing latest disruptions in the biopharma industry
  • Corporate venture funds role in supporting Biotech commercialisation
  • Re-thinking manufacturing productivity and quality
  • Connecting human resources, data, machines and networks for better outcomes
  • Data management, product traceability and supply chain security
  • Managing costs on cold and non-cold chain logistics costs

5:00 pm

End of Conference Day 2

9:00 am

Investing in high potential pharma and biotech could be very profitable. Funds are needed from R&D stage to commercialisation. This full-day workshop will guide you through a step by step approach in capital raising, gaining the best exposure from your ROI and ultimately mange your risk.

Key Learning points included, but not limited to:

  • How to successfully raise finance for Biotech companies both matured and startups
  • Venture capital firms views on investing in biotech
  • Preparing for your strong pitch
  • Understanding regulatory framework
  • Key understanding on IRR

Co Located with BioPharma Development and Production Week, the Biotech Investment Summit 2018 will bring together top dealmakers from regional and international financial markets, and the biotech industry. Central to the conference objectives will be connecting investors with biotech, with extensive company showcases by CEO, CFO, CSO, emerging market opportunities and a specific focus on R&D investment in southeast Asia. In addition, practical tools for investment appraisal, capital raising models and deal structuring tactics will be discussed.

1:00 pm

End of workshop


Packages Price
2 Day ConferenceSGD $2895Early Bird
Extras Price
Pre-Conference Workshop SGD $800

Early Bird Rate: Register & Pay by 7 September 2018

Special 1-for-1 Offer on Normal Rates for Pharmaceutical and Biotech Companies*
Limited seats, applicable only to 2-day main conference days.
Email to find out more!

*The organizer reserves the right to determine the industry to which your company belongs, and to stop the promotion at any stage.

Register 2 Delegates and get 1 FREE PASS
Register 3 Delegates and get 2 FREE PASS
Register 5 Delegates and get 3 FREE PASS
(Group rate is based on normal rate of 2-day main conference package only)

For Group Registrations of more than 3 team members,
email or call +65 6508 2477

  • Multiple Bookings Discount pricing is applicable to groups of 3 or more delegates from the same organisation registering for the same event, at the same time.
  • Fee stated is the discounted price PER DELEGATE. Only one discount applies; either the early bird rate OR group rate.
  • All fees stated include luncheons, refreshments and complete set of documentation. It does not include the cost of accommodation and travel.
  • All delegates from Singapore-based companies are required to pay an additional 7% GST (SINGAPORE EVENTS ONLY)


Partnership and Profile Building Opportunities are Now Available!
Contact us today to find out how you can position your company as a market leader at this event, and to explore the range of branding and marketing opportunities available.


Ming-Qiang Zhang

Vice-President, Research & Development, Amgen, China

Dr. Carl Firth

Founder and Chief Executive Officer, Aslan Pharmaceuticals Pte Ltd, Singapore

Piers Ingram

Chief Executive Officer, Hummingbird Bioscience, Singapore

Jonathan Zhao

PhD, Co-founder and Chief Executive Officer, Hangzhou JUST Biotherapeutics, China

Ryan Viegas

Head of Logistics - APAC, Teva

Jinpian Diao-Piezunka

Head of Bioprocess Development, Sanofi, France

Dr Damian Tan

Managing Director, Vickers Venture Partners Singapore

Dr. Ming-Chu Hsu

Chairman and Chief Executive Officer, TaiGen Biotechnology, Taiwan

Jeffrey Lu

Co-Founder, Chief Executive Officer, Board Director, Engine Bioscience, Singapore

Emil Tsai

Chief Executive Officer, SyneuRx International (Taiwan) Corp

Wen Luo

CEO/CSO, Denovo Biopharma LLC, U.S.

Dr. Li Zhu

Chief Strategy Officer, GenScript and Legend Biotech, China

Dr. Poon Thong Yuen

Chief Strategy Officer, Histoindex, Singapore

Greg Collier

Managing Director & CEO, Invion Limited, Australia

Dr. Lim Xinhong

Venture Principal, Vickers Venture Partners Singapore

Eugene Hong

Senior Vice President, DBS Bank, Singapore

Marietta Wu

Managing Director, Quan Capital, China

Kenneth Noonan

Chief Executive Officer, Lightstone Singapore

Neo Kah Yean

Senior Vice President, Commercialisation for Biomedical Sciences ETPL A*STAR

Venkateswarlu Nelabhotla (N. Venkat)

CEO & Board Member, VYOME India

Vishal Doshi

Chief Executive Officer, AUM Biosciences, Singapore

Dr. Lietao LI

Chief Executive Officer, LION TCR, Singapore

Joseph Albert

Chief Technical Officer – Engineering and Projects, AJ Pharma Holding, Malaysia

Liang Tang

Vice President of Biologics Development and Manufacturing, WuXi Biologics, China

when & where

31 Oct - 02 Nov 2018

One Farrer Hotel & Spa
1 Farrer Park Station Road
Singapore 217562

Contact Person: Daniel Koh
DDI: (+65) 6705 7884
Fax: (+65) 6834 7892
Cell: (+65) 86870123


Still have a question?

Media & Association Partnership Opportunities
Tham Ruohyi
+65 6508 2463

Sponsorship Opportunities
Yvonne Leong 
+65 6508 2489

Speaking Opportunities
Sophia Zhao
+65-6508 2491


Supporting Association


IBC Asia is Singapore's leading event organiser. We conceive, develop and promote our own B2B industry conferences and corporate training courses, and offer tailored managed event solutions.

Find out more